Chenxia Hu; Lingfei Zhao; Lingjian Zhang; Qiongling Bao; Lanjuan Li · 2020 · Stem Cell Research & Therapy
Paper
Abstract Various hepatoxic factors, such as viruses, drugs, lipid deposition, and autoimmune responses, induce acute or chronic liver injury, and 3.5% of all worldwide deaths result from liver cirrhosis, liver failure, or hepatocellular carcinoma. Liver transplantation is currently limited by few liver donors, expensive surgical costs, and severe immune rejection. Cell therapy, including hepatocyte transplantation and stem cell transplantation, has recently become an attractive option to reduce the overall need for liver transplantation and reduce the wait time for patients. Recent studies showed that mesenchymal stem cell (MSC) administration was a promising therapeutic approach for promoting liver regeneration and repairing liver injury by the migration of cells into liver sites, hepatogenic differentiation, immunoregulation, and paracrine mechanisms. MSCs secrete a large number of molecules into the extracellular space, and soluble proteins, free nucleic acids, lipids, and extracellular vesicles (EVs) effectively repair tissue injury in response to fluctuations in physiological states or pathological conditions. Cell-free-based therapies avoid the potential tumorigenicity, rejection of cells, emboli formation, undesired differentiation, and infection transmission of MSC transplantation. In this review, we focus on the potential mechanisms of MSC-based cell-free strategies for attenuating liver injury in various liver diseases. Secretome-mediated paracrine effects participate in the regulation of the hepatic immune microenvironment and promotion of hepatic epithelial repair. We look forward to completely reversing liver injury through an MSC-based cell-free strategy in regenerative medicine in the near future.
Analysis
This paper reviews mesenchymal stem cell (MSC)-based cell-free strategies as a promising and safer alternative to MSC transplantation for treating liver injury.
Discovery
Hany E. Marei
Wenzhao Cheng; Yiming Zeng; Dachun Wang
Mourad A. M. Aboul‐Soud; Alhusain J. Alzahrani; Amer Mahmoud
Sharif Moradi; Hamid Mahdizadeh; Tomo Šarić; Johnny Kim; Javad Harati; Hosein Shahsavarani; Boris Greber; Joseph B. Moore
Yu Han; Xuezhou Li; Yanbo Zhang; Yanbo Zhang; Yuping Han; Jianxun Ding
Barbara Łukomska; Luiza Stanaszek; Ewa Zuba‐Surma; Paweł Łęgosz; Sylwia Sarzyńska; Katarzyna Drela
Source record